Last year, I conducted a series of interviews with GPs in order to understand their experiences with anticoagulation management in patients with atrial fibrillation (AF). It is well known that AF is the most common arrhythmia seen in Australian general practice, and that the use of anticoagulants is a well-established intervention to reduce the risk of thromboembolism. This is reflected in the 2018 National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand AF guidelines.
As such, I wanted to know more about GPs’ experiences with anticoagulation, and any barriers they may have with initiating anticoagulation. Below is what I found out from the research study:
For more information, see the published paper
If you are interested in the latest clinical updates on AF, and multiple other general practice topics, join us in February for our signature CPD program, the 2022 version of Hot Topics GP Update course.
Eyob Gebreyohannes (PhD candidate at the University of Western Australia – Optimising anticoagulation in atrial fibrillation in Australian general practice setting.)
Email: [email protected]
BPharm, MSc, Ph.D. Candidate
Division of Pharmacy • School of Allied Health
Faculty of Health and Medical Sciences, University of Western Australia
Become a member and get unlimited access to 100s of hours of premium education.
Learn moreAchilles tendinopathy is a common cause of posterior heel pain and functional impairment. GPs are well-placed to coordinate care for these patients. This FastTrack fact sheet provides a concise summary of diagnosis and non-surgical management, including when to refer. Earn 30mins each RP and EA CPD with the quiz.
Over 3% of GP consultations in Australia involve skin lesions, yet many practices are billing these procedures incorrectly, putting themselves at risk of noncompliance or missing out on legitimate remuneration. This Business skills FastTrack explains the MBS item numbers pertaining to skin lesions for GPs, including eligibility criteria and practical tips.
With one in three young Australians experiencing a mental health condition each year, and suicide remaining the leading cause of death for 16 to 24-year-olds, the way clinicians approach antidepressant use in teens and young adults has never been more important.